Source: EURLEX
Language: en
Format: md

|  |  |  |
| --- | --- | --- |
| European flag | Official Journal  of the European Union | EN  C series |

---

|  |  |  |
| --- | --- | --- |
|  | C/2024/3801 | 24.6.2024 |

Action brought on 13 May 2024 – Serana Europe v EUIPO – Cytogen Produkte für Medizin + Forschung (Lymphogrow)

(Case T-250/24)

(C/2024/3801)

Language in which the application was lodged: German

Parties

Applicant: Serana Europe GmbH (Pessin, Germany) (represented by: T. Bösling and I. George, lawyers)

Defendant: European Union Intellectual Property Office

Other party to the proceedings before the Board of Appeal: Cytogen Produkte für Medizin + Forschung GmbH (Greven, Germany)

Details of the proceedings before EUIPO

Applicant for the trade mark at issue: Applicant

Trade mark at issue: Application for the EU word mark Lymphogrow – Application No 18 567 547

Proceedings before EUIPO: Opposition proceedings

Contested decision: Decision of the Second Board of Appeal of EUIPO of 12 March 2024 in Case R 1707/2023-2

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | amend the contested decision to the effect that the opposition filed by Cytogen Produkte für Medizin + Forschung GmbH against EU trade mark application No 18 567 547 ‘Lymphogrow’ is rejected and the appellant before the Board of Appeal is ordered to pay the costs of the proceedings before the Board of Appeal; |

|  |  |
| --- | --- |
| — | in the alternative, annul the contested decision; |

|  |  |
| --- | --- |
| — | order EUIPO to pay the costs. |

Plea in law

Infringement of Article 8(4) in conjunction with Article 71 of Regulation (EU) 2017/1001 of the European Parliament and of the Council.

---

[Top](#document1)